Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Systemic administration of PRO051 in Duchenne's muscular dystrophy.

Goemans NM, Tulinius M, van den Akker JT, Burm BE, Ekhart PF, Heuvelmans N, Holling T, Janson AA, Platenburg GJ, Sipkens JA, Sitsen JM, Aartsma-Rus A, van Ommen GJ, Buyse G, Darin N, Verschuuren JJ, Campion GV, de Kimpe SJ, van Deutekom JC.

N Engl J Med. 2011 Apr 21;364(16):1513-22. doi: 10.1056/NEJMoa1011367. Epub 2011 Mar 23. Erratum in: N Engl J Med. 2011 Oct 6;365(14):1361.

2.

A combinatorial approach toward the generation of ambiphilic peptide-based inhibitors of protein:geranylgeranyl transferase-1.

El Oualid F, van den Elst H, Leroy IM, Pieterman E, Cohen LH, Burm BE, Overkleeft HS, van der Marel GA, Overhand M.

J Comb Chem. 2005 Sep-Oct;7(5):703-13.

PMID:
16153065
3.

Design, synthesis, and evaluation of sugar amino acid based inhibitors of protein prenyl transferases PFT and PGGT-1.

El Oualid F, Burm BE, Leroy IM, Cohen LH, van Boom JH, van den Elst H, Overkleeft HS, van der Marel GA, Overhand M.

J Med Chem. 2004 Jul 29;47(16):3920-3.

PMID:
15267228
4.

Antiproliferative effect in chronic myeloid leukaemia cells by antisense peptide nucleic acids.

Rapozzi V, Burm BE, Cogoi S, van der Marel GA, van Boom JH, Quadrifoglio F, Xodo LE.

Nucleic Acids Res. 2002 Sep 1;30(17):3712-21.

5.

Inhibitors of prenylation of Ras and other G-proteins and their application as therapeutics.

Cohen LH, Pieterman E, van Leeuwen RE, Overhand M, Burm BE, van der Marel GA, van Boom JH.

Biochem Pharmacol. 2000 Oct 15;60(8):1061-8. Review.

PMID:
11007942

Supplemental Content

Loading ...
Support Center